RTS Life Science Launches Revolutionary Automated Blood Fractionation System at European Spring Biobanking and Biorepositories 2008

RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems, today announces that it will be launching its revolutionary Automated Blood Fractionation (ABF) system at European Spring Biobanking and Biorepositories 2008,15-16 April, Zurich, Switzerland. This unique patent-pending* high throughput blood fractionation system is used to extract buffy coat (white blood cells) from whole blood samples.

The innovative, upgradable system provides a fully automated solution to blood fractionation and processing. The ABF system is a self-contained unit capable of processing up to 500 samples per day, providing substantial time and labour cost savings compared with manual fractionation. In addition, this new automated system from RTS Life Science provides the benefits of cost and labour saving, removal of human error, increased reproducibility and facilitation of sample tracking and auditing.

The revolutionary ABF system incorporates unique Vision System technology which measures the height of each fraction and calculates the volume of each layer following fractionation via centrifugation. The ABF solution also offers significant health and safety benefits by reducing employee exposure to unscreened blood and a LIMS (Laboratory Information Management System) interface ensures ease of acquisition and manipulation of data.

Kristian Spreckley, Blood Fractionation Product Manager at RTS Life Science comments, “RTS has developed this new ABF system in response to the unique needs of the biobanking industry. The system should be installed to automate blood fractionation and buffy coat retrieval from whole blood in any high volume environment.”

As well as the fully Automated Blood Fractionation System, RTS also offers this solution as a semi-automated system. To be among the first to see this innovative new offering from RTS Life Science please visit Biobanking and Biorepositories 2008, 15-16 April, Zurich, Switzerland.

*Patent Application Number 0422358.2